Evidence map›Paper›PMID 10376526›Full record

ArticleOncogene1999

Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation.

F E Jones, D F Stern

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Busting the Breast Cancer with AstraZeneca's Gefitinib.Advances in pharmacological and pharmaceutical sciences · 2023
    Review
  3. Breast cancer (Dove Medical Press) · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Fatty acid synthase is required for mammary gland development and milk production during lactation.American journal of physiology. Endocrinology and metabolism · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Targeting HER2 in breast cancer: overview of long-term experience.International journal of women's health · 2010
    Article
  16. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.Journal of mammary gland biology and neoplasia · 2008
    Review
  17. The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.Journal of mammary gland biology and neoplasia · 2008
    Review
  18. Article
  19. Vaccines for tumour prevention.Nature reviews. Cancer · 2006
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

F E JonesDepartment of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.
D F Stern
Yale University · US

Funding

TRANSFORMATION BY THE NEU ONCOGENE PRODUCT AND EGFR01CA045708 · NCI · YALE UNIVERSITY · PI STERN, DAVID F · 1987 to 2011
$3.8M
NCI NIH HHS R01CA45708
6 · The paper itself

Abstract

Overexpression of the receptor tyrosine kinase ErbB2/HER2/Neu (ErbB2) occurs in 15-40% of human breast cancers. To determine the function of ErbB2 signaling during normal mouse mammary gland development, we expressed a carboxyl-terminal truncated dominant negative allele of ErbB2 (ErbB2deltaIC) in the developing mouse mammary gland. Despite ErbB2deltaIC expression within mammary glands of pubescent virgin and pregnant mice, a phenotype was not observed until late in pregnancy. At 1 day post-partum, lactationally active, distended lobuloalveoli failed to form. This phenotype was exaggerated in multiparous females expressing ErbB2deltaIC. Immunohistochemical staining for ErbB2deltaIC revealed a concordance between high levels of ErbB2deltaIC protein expression and the absence of lactational products within the lumens of ErbB2deltaIC stained lobuloalveoli. These results demonstrate that ErbB2 signaling is required for proper mammary development and lactation at parturition.

Indexed as

3T3 CellsAnimalsErb-b2 Receptor Tyrosine KinasesFemaleLactationMammary Glands, AnimalMiceMice, TransgenicPhenotypePhosphorylationPregnancyRatsSignal TransductionErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID10376526
OpenAlexW2322271523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.